Companies: 48,687 Total Market Cap: 127308871272626.81

TalkMed Group Limited

SGX-5G3
Miscellaneous Health And Allied Services, Not Elsewhere Classified
Rank #13911
Market Cap 450.76 M
Volume 0
Price 0.34
Change (%) 0.00%
Country or region Singapore Singapore

TalkMed Group Limited's latest marketcap:

450.76 M

As of May 3, 2025, TalkMed Group Limited's market capitalization has reached $450.76 M. According to our data, TalkMed Group Limited is the 13911th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 450.76 M
Revenue (ttm) 60.21 M
Net Income (ttm) 33.72 M
Shares Out 1.33 B
EPS (ttm) 0.03
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date April 24, 2025
Market Cap Chart
Data Updated: May 3, 2025

TalkMed Group Limited's yearly market capitalization.

TalkMed Group Limited has seen its market value drop from S$593.12 M to S$585.32 M since 2020, representing a total decrease of 1.32% and an annual compound decline rate (CAGR) of 0.31%.
Date Market Cap Change (%)
April 30, 2025 S$585.32 M -1.04%
December 31, 2024 S$591.47 M 17.42%
December 28, 2023 S$503.70 M -4.79%
December 27, 2022 S$529.02 M 2.75%
December 28, 2021 S$514.84 M -13.2%
December 31, 2020 S$593.12 M

Company Profile

About TalkMed Group Limited

TalkMed Group Limited is an investment holding company specializing in advanced medical services across multiple regions, including Singapore, China, Hong Kong, Vietnam, India, New Zealand, Australia, and the United States.

Core Business Segments

  • Oncology Services – Specializing in breast, colon, lung, liver, pancreatic, gastrointestinal, head and neck, genitourinary, gynecological, and hematological malignancies, as well as brain cancers, lymphoma, and leukemia.
  • Cellular and Gene Therapy – Developing innovative processing platforms for cell and gene therapy, including genetic modification of immune cells and viral vector technologies.

Key Services

  • Medical Oncology – Comprehensive cancer treatment and management.
  • Palliative Care – Cancer pain management, home care planning, and end-of-life care services.
  • Ancillary Health Services – Including CANSCREEN, a specialized cancer screening program.
  • Healthcare Management – Specialist doctor and clinical staff services.

Research & Innovation

The company is actively involved in pioneering research, focusing on genetic modification of immune cells and novel viral vector technologies to enhance cellular therapy.

Founded in 1997 and headquartered in Singapore, TalkMed Group Limited operates as a subsidiary of Citibank Nominees Singapore Pte Ltd.

Frequently Asked Questions

As of May 3, 2025, TalkMed Group Limited (including the parent company, if applicable) has an estimated market capitalization of $450.76 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

TalkMed Group Limited global market capitalization ranking is approximately 13911 as of May 3, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Singapore
Founded 1997
IPO Date n/a
Employees 235
CEO Peng Tiam Ang
Sector
Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Address 3 Mount Elizabeth
Singapore, 228510
Singapore
People Also Watch
OTC-NPXYY
15.90 1.92%
ASE-APOT
38.96 1.92%
HOSE-GVR
0.90 1.92%
SHA-688548
1.52 1.92%